Thailand PM to Open International Symposium in Bangkok on Stem Cell Therapy for the Failing hHeart

Bangkok, Thailand (PRWEB) November 28, 2006

Delegates from around the world will join leading scientists and researchers, medical specialists and industry leaders at a stem cell therapy symposium in Bangkok, December, 1-3, 2006. The symposium is co-sponsored by the Bangkok Heart Hospital and TheraVitae.

The Prime Minister of Thailand, General Surayud Chulanont, will open the three-day event which has been organized to provide a forum where the latest clinical techniques and current research can be discussed. This will facilitate better insight into the emerging technologies and techniques of helping those who suffer from cardiac disease.

President of TheraVitae, Thailand, Mr. Narin Apichairak, said: "We are honored and excited to be a co-sponsor of this event. We are at the dawn of a new era in medicine and it is essential that both healthcare providers and the public understand the true benefits of stem cells."

"I'm delighted to have such positive support from the Thai Government as well as prominent people from within the industry. With the governments' support, Thailand is poised to become a major international player in the field of regenerative medicine."

Interested parties can view the full details of the symposium on http://www.stemcellbangkok.com

About TheraVitae

TheraVitae is a private, multinational company focused on using stem cells from the patient's own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has developed a proprietary stem cell technology, 'VesCell', that is currently being used by hospitals in Thailand and Singapore to treat patients with heart disease.

VesCell -- A Natural Treatment for Heart Disease

The body has natural ways of healing itself and the cardiovascular system is no exception. Angiogenic Cell Precursors (ACPs) originate in bone marrow and then circulate in the blood vessels. To manufacture VesCell, TheraVitae expands a small number of ACPs harvested from about 250cc of blood into a therapeutic quantity. VesCell is injected either through a coronary artery via catheter, or during surgery, directly into the heart muscle.

A key aspect of VesCell therapy is the advanced cell isolation and expansion technique that allows for the ACPs to be harvested from blood collected in a procedure similar to a common blood donation. VesCell uses a patient's own adult stem cells to treat Heart Disease and is a viable therapeutic possibility for heart patients without any other treatment option.

TheraVitae Corporate Web Site: http://www.theravitae.com
VesCell Web Site: http://www.VesCell.com

TheraVitae Thailand

36/72 PS Tower, 21/Fl., Sukhumvit 21, Klongtoey Nua, Bangkok 10110

Phone: 02-664-4290

Fax: 02-664-4289

Theravitae Israel

7 Pinhas Sapir Street P.O. Box 4049, Ness Ziona 74140, Israel

Phone: +972-8-9409170

###